Patisiran

Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection
BioSpace
Thu, 10/26/23 - 10:39 am
Alnylam
Patisiran
clinical trials
FDA
ATTR with cardiomyopathy
FDA denies expanded approval for Alnylam RNA drug
BioPharma Dive
Mon, 10/9/23 - 10:15 am
Alnylam
FDA
RNA
Patisiran
ATTR amyloidosis
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Fri, 09/28/18 - 10:34 am
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
CP Wire
Fri, 09/14/18 - 09:40 am
Alnylam
Patisiran
hATTR amyloidosis
Onpattro
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
Fri, 09/14/18 - 09:35 am
Alnylam
hATTR amyloidosis
Patisiran
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
Xconomy
Thu, 08/30/18 - 10:20 am
RNAi
Alynylam
Europe
Onpattro
hATTR
Patisiran
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Tue, 08/14/18 - 12:06 am
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Fri, 08/10/18 - 02:25 pm
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
With patisiran launch in its sights, Alnylam plots a major hiring spree
Fierce Pharma
Tue, 08/7/18 - 12:02 pm
Alnylam
Patisiran
RNAi
hirings
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
Sun, 08/5/18 - 07:25 pm
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
Xconomy: Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
Xconomy
Fri, 08/3/18 - 11:45 am
FDA
Alynylam
Patisiran
hATTR amyloidosis
The UK's MHRA Grants Early Access to Anlylam's Patisiran
CP Wire
Fri, 08/3/18 - 09:23 am
Alnylam
Patisiran
hATTR amyloidosis
UK
The UK's MHRA Grants Early Access to Anlylam's Patisiran
Fri, 08/3/18 - 09:01 am
Alnylam
Patisiran
hATTR amyloidosis
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
CP Wire
Fri, 07/27/18 - 10:22 am
Alnylam
Patisiran
EMA
hATTR amyloidosis
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
Fri, 07/27/18 - 10:01 am
Alnylam
Patisiran
hATTR amyloidosis
Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis
CP Wire
Mon, 07/23/18 - 09:42 am
Alnylam
Patisiran
hereditary ATTR amyloidosis
Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis
Mon, 07/23/18 - 09:40 am
Alnylam
hereditary ATTR amyloidosis
Patisiran
FDA Extends Action Date on Akcea's Inotersen, Alnylam Now in Lead
CP Wire
Fri, 05/4/18 - 09:58 am
Akcea
hereditary ATTR amyloidosis
FDA
inotersen
Alnylam
Patisiran
FDA Extends Action Date on Akcea's Inotersen, Alnylam Now in Lead
Fri, 05/4/18 - 09:54 am
Akcea Therapeutics
inotersen
Alnylam
Patisiran
Why Pfizer's Big Win Is Bad News for Alnylam and Ionis
Yahoo/Motley Fool
Mon, 04/2/18 - 03:07 pm
Pfizer
Alnylam
Ionis Pharmaceuticals
tafamidis
inotersen
Patisiran

Pages